GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Therapeutics Inc (STU:2UV) » Definitions » Institutional Ownership

Applied Therapeutics (STU:2UV) Institutional Ownership : 18.10% (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Applied Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Applied Therapeutics's institutional ownership is 18.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Applied Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Applied Therapeutics's Float Percentage Of Total Shares Outstanding is 89.45%.


Applied Therapeutics Institutional Ownership Historical Data

The historical data trend for Applied Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Therapeutics Institutional Ownership Chart

Applied Therapeutics Historical Data

The historical data trend for Applied Therapeutics can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 25.99 22.09 21.45 27.66 28.39 23.94 15.75 17.69 18.16 18.10

Applied Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Applied Therapeutics Business Description

Traded in Other Exchanges
Address
545 Fifth Avenue, Suite 1400, New York, NY, USA, 10017
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.

Applied Therapeutics Headlines

No Headlines